We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.35%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.77B
AUM Growth
+$335M
(+5.2%)
Cap. Flow
-$383M
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
27.24%
Holding
1,412
New
326
Increased
336
Reduced
315
Closed
394
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$112M |
| 2 |
Labcorp
LH
|
+$102M |
| 3 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$70.5M |
| 4 |
CONMED
CNMD
|
+$63.7M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
+$49.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$234M |
| 2 |
AGN
Allergan plc
AGN
|
+$196M |
| 3 |
Cardinal Health
CAH
|
+$121M |
| 4 |
Tenet Healthcare
THC
|
+$74.9M |
| 5 |
MetLife
MET
|
+$71.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.79% |
| 2 | Miscellaneous | 19.62% |
| 3 | Energy | 7.81% |
| 4 | Consumer Discretionary | 6.07% |
| 5 | Financials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MZOR
476
DELISTED
Mazor Robotics Ltd.
MZOR
| $1.71M | 0.03% |
145,000
-155,000
| -52% | -$2.16M |
|
477
Nu Skin
NUS
$223M
| $1.69M | 0.02% |
+37,444
| New | +$1.99M |
|
|
BRSL
478
Brightstar Lottery PLC
BRSL
$1.93B
| $1.67M | 0.02% |
98,900
-148,165
| -60% | -$2.47M |
|
479
PUT
Nike
NKE
$53.1B
| $1.67M | 0.02% |
+374
| New | +$14.8K |
|
|
SEEL
480
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $1.66M | 0.02% |
1
| – | – |
|
481
Akebia Therapeutics
AKBA
$254M
| $1.66M | 0.02% |
74,768
| – | – |
|
|
JAH
482
DELISTED
JARDEN CORPORATION
JAH
| $1.64M | 0.02% |
40,868
-14,988
| -27% | -$587K |
|
|
BNY
483
Bank of New York Mellon
BNY
$104B
| $1.61M | 0.02% |
+41,702
| New | +$1.62M |
|
484
RTX Corp
RTX
$265B
| $1.61M | 0.02% |
24,296
+4,754
| +24% | +$326K |
|
485
Achieve Life Sciences
ACHV
$766M
| $1.6M | 0.02% |
272
| – | – |
|
486
RLI Corp
RLI
$5.56B
| $1.56M | 0.02% |
+72,118
| New | +$1.61M |
|
|
PETX
487
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.56M | 0.02% |
155,136
| – | – |
|
|
NSTG
488
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.56M | 0.02% |
142,300
-473,500
| -77% | -$5.86M |
|
489
Carter's
CRI
$1.07B
| $1.55M | 0.02% |
+20,000
| New | +$1.55M |
|
490
Bank of Hawaii
BOH
$2.95B
| $1.54M | 0.02% |
+27,202
| New | +$1.57M |
|
491
Verizon
VZ
$207B
| $1.54M | 0.02% |
30,800
-92,659
| -75% | -$4.61M |
|
492
Crown Castle
CCI
$31.2B
| $1.53M | 0.02% |
+19,049
| New | +$1.47M |
|
493
Constellium
CSTM
$3.51B
| $1.51M | 0.02% |
61,346
-4,647
| -7% | -$134K |
|
|
CRZO
494
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $1.51M | 0.02% |
+28,064
| New | +$1.71M |
|
|
TRW
495
PUT
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $1.5M | 0.02% |
+148
| New | +$14.8K |
|
|
CVO
496
DELISTED
Cenevo, Inc.
CVO
| $1.49M | 0.02% |
75,338
+12,838
| +21% | +$330K |
|
|
VXRT
497
DELISTED
Vaxart
VXRT
| $1.48M | 0.02% |
54,545
| – | – |
|
|
LXK
498
DELISTED
Lexmark Intl Inc
LXK
| $1.48M | 0.02% |
34,769
+29,443
| +553% | +$1.42M |
|
499
ConocoPhillips
COP
$159B
| $1.48M | 0.02% |
+19,306
| New | +$1.58M |
|
|
S
500
DELISTED
Sprint Corporation
S
| $1.46M | 0.02% |
231,012
-91,531
| -28% | -$623K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, Visium Asset Management held 1,412 positions worth $6.77B, up 5.2% from $6.44B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Visium Asset Management withdrew a net $383M in Q3 2014, closing 394 positions and reducing 315 holdings. Its most notable exit was Pacira BioSciences, an estimated $40.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 53% a quarter earlier, followed by Miscellaneous and Energy.
Against the trend, Visium Asset Management opened a new position in Liberty TripAdvisor Holdings, Inc. Series A worth $21.9M.
- Visium Asset Management's largest Q3 2014 buy was Liberty TripAdvisor Holdings, Inc. Series A: 646,673 shares worth $21.9M.
- Visium Asset Management added most to Elevance Health in Q3 2014, an estimated $112M increase.
- Visium Asset Management's biggest Q3 2014 reduction was Allergan Inc, cutting an estimated $234M.
- Visium Asset Management fully exited Pacira BioSciences in Q3 2014, selling an estimated $40.3M.
- Visium Asset Management's ten largest holdings make up 27% of its $6.77B portfolio in Q3 2014.
- Visium Asset Management opened 326 new positions and closed 394 in Q3 2014.
- Visium Asset Management's portfolio value rose 5.2% quarter-over-quarter to $6.77B.
Based on Visium Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.